LEP and Alzheimer disease: Although previous studies suggest that amyloid is also capable of attenuating hypothalamic neuron reactivity to leptin and ghrelin [24], evidence from both mouse models and AD patients suggest that hypothalamic impairment and metabolic abnormalities precede amyloid and tau pathology [2, 113].